RepliCel Life Sciences Inc. P6P2.F Stock
RepliCel Life Sciences Inc. Price Chart
RepliCel Life Sciences Inc. P6P2.F Financial and Trading Overview
RepliCel Life Sciences Inc. stock price | 0.0080 EUR |
Previous Close | 0.13 EUR |
Open | 0.13 EUR |
Bid | 0.13 EUR x 0 |
Ask | 0.19 EUR x 0 |
Day's Range | 0.13 - 0.13 EUR |
52 Week Range | 0.02 - 0.15 EUR |
Volume | 1.5K EUR |
Avg. Volume | 258 EUR |
Market Cap | 9.24M EUR |
Beta (5Y Monthly) | 1.06514 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
P6P2.F Valuation Measures
Enterprise Value | 10.07M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 26.11312 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 28.469 |
Enterprise Value/EBITDA | -6.689 |
Trading Information
RepliCel Life Sciences Inc. Stock Price History
Beta (5Y Monthly) | 1.06514 |
52-Week Change | 136.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.15 EUR |
52 Week Low | 0.02 EUR |
50-Day Moving Average | 0.08 EUR |
200-Day Moving Average | 0.06 EUR |
P6P2.F Share Statistics
Avg. Volume (3 month) | 258 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 65M |
Float | 23.06M |
Short Ratio | N/A |
% Held by Insiders | 55.22% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -259.87% |
Operating Margin (ttm) | -425.81% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -121.0040% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 353.74K EUR |
Revenue Per Share (ttm) | 0.008 EUR |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | N/A |
EBITDA | -1505525 EUR |
Net Income Avi to Common (ttm) | -919267 EUR |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 697.26K EUR |
Total Cash Per Share (mrq) | 0.01 EUR |
Total Debt (mrq) | 757.38K EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.566 |
Book Value Per Share (mrq) | -0.09 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2194473 EUR |
Levered Free Cash Flow (ttm) | -1213566 EUR |
Profile of RepliCel Life Sciences Inc.
Country | Germany |
State | BC |
City | Vancouver |
Address | 570 Granville Street |
ZIP | V6C 3P1 |
Phone | 604-248-8730 |
Website | https://www.replicel.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. The company is headquartered in Vancouver, Canada.
Q&A For RepliCel Life Sciences Inc. Stock
What is a current P6P2.F stock price?
RepliCel Life Sciences Inc. P6P2.F stock price today per share is 0.0080 EUR.
How to purchase RepliCel Life Sciences Inc. stock?
You can buy P6P2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RepliCel Life Sciences Inc.?
The stock symbol or ticker of RepliCel Life Sciences Inc. is P6P2.F.
Which industry does the RepliCel Life Sciences Inc. company belong to?
The RepliCel Life Sciences Inc. industry is Biotechnology.
How many shares does RepliCel Life Sciences Inc. have in circulation?
The max supply of RepliCel Life Sciences Inc. shares is 304.37M.
What is RepliCel Life Sciences Inc. Price to Earnings Ratio (PE Ratio)?
RepliCel Life Sciences Inc. PE Ratio is now.
What was RepliCel Life Sciences Inc. earnings per share over the trailing 12 months (TTM)?
RepliCel Life Sciences Inc. EPS is -0.01 EUR over the trailing 12 months.
Which sector does the RepliCel Life Sciences Inc. company belong to?
The RepliCel Life Sciences Inc. sector is Healthcare.